You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Drugs Containing Excipient (Inactive Ingredient) AMMONIUM CHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


Generic drugs containing AMMONIUM CHLORIDE excipient

AMMONIUM CHLORIDE: MARKET DYNAMICS AND FINANCIAL TRAJECTORY

Last updated: February 19, 2026

What is the current market size and projected growth for ammonium chloride?

The global ammonium chloride market was valued at USD 1.02 billion in 2023 and is projected to reach USD 1.31 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 3.6% during the forecast period [1]. This growth is driven by its diverse applications across various industries, including pharmaceuticals, agriculture, and industrial manufacturing [2]. The pharmaceutical sector, in particular, represents a significant and growing segment for ammonium chloride consumption due to its use as an excipient [3].

What are the primary applications of ammonium chloride in the pharmaceutical industry?

In pharmaceuticals, ammonium chloride functions primarily as an excipient, a pharmacologically inactive substance formulated alongside the active pharmaceutical ingredient (API) of a medication [4]. Its key roles include:

  • Respiratory Expectorant: Ammonium chloride is a well-established ingredient in cough syrups and other expectorant formulations. It works by irritating the gastric mucosa, which reflexively stimulates the secretion of respiratory tract fluids. This increases the volume and reduces the viscosity of bronchial secretions, facilitating their removal through coughing [5]. This application is particularly prevalent in over-the-counter (OTC) cold and cough remedies.
  • pH Regulator: Ammonium chloride is used to adjust and maintain the pH of pharmaceutical formulations. Its acidic nature can be utilized to lower the pH of solutions, which is crucial for the stability and efficacy of certain APIs [6]. This is important in the manufacturing of intravenous (IV) solutions and other sterile preparations.
  • Buffering Agent: In some pharmaceutical preparations, ammonium chloride acts as a buffering agent, helping to resist changes in pH when small amounts of acid or base are added. This is essential for maintaining the consistent environment required for drug stability and patient administration [7].
  • Dyes and Pigments for Pharmaceutical Coatings: Ammonium chloride is utilized in the production of certain dyes and pigments that are applied to pharmaceutical tablets and capsules for identification or aesthetic purposes [8].

Which geographic regions dominate the ammonium chloride market, and what are the drivers for these regions?

The Asia-Pacific region is the largest and fastest-growing market for ammonium chloride, accounting for approximately 40% of the global market share in 2023 [1]. This dominance is attributed to several factors:

  • Robust Pharmaceutical Manufacturing Hubs: Countries like China and India are major global producers of both generic and branded pharmaceuticals, driving significant demand for excipients, including ammonium chloride [9].
  • Growing Healthcare Expenditure: Increasing healthcare spending and an expanding middle class in the Asia-Pacific region lead to higher demand for OTC and prescription medications, further boosting excipient consumption [10].
  • Agricultural Demand: While not a pharmaceutical application, the significant agricultural sector in Asia-Pacific, which uses ammonium chloride as a nitrogen fertilizer, also contributes to the region's overall market dominance and influences supply chains [2].

North America and Europe represent the second and third largest markets, respectively. These regions are characterized by established pharmaceutical industries, stringent regulatory standards, and a high prevalence of respiratory ailments, supporting consistent demand for ammonium chloride as an expectorant and excipient [1].

What are the key raw materials and manufacturing processes for ammonium chloride?

The primary raw materials for the production of ammonium chloride are ammonia (NH₃) and hydrogen chloride (HCl) [11].

The most common manufacturing processes include:

  • Solvay Process Byproduct: A significant portion of industrially produced ammonium chloride is obtained as a byproduct of the Solvay process, which is used for the production of sodium carbonate (soda ash) [12]. In this process, ammonia and carbon dioxide are passed through a brine solution, and ammonium chloride is a co-product.
  • Direct Synthesis: Ammonium chloride can also be synthesized directly by reacting ammonia gas with hydrogen chloride gas: NH₃ (g) + HCl (g) → NH₄Cl (s) [11] This reaction is exothermic and produces solid ammonium chloride.

The purity of the ammonium chloride produced is critical for pharmaceutical applications. Pharmaceutical-grade ammonium chloride must meet stringent pharmacopeial standards (e.g., USP, EP, JP) regarding impurity profiles, heavy metals, and other contaminants [13].

What is the competitive landscape for pharmaceutical-grade ammonium chloride manufacturers?

The market for pharmaceutical-grade ammonium chloride is moderately consolidated, with several key global players and a number of regional manufacturers [1]. Major companies involved in the production and supply of ammonium chloride for pharmaceutical applications include:

  • OCI Company Ltd.
  • Tessenderlo Group
  • Saha Española
  • Chinese Fertilizer Industry Association Members (various)
  • Uralchem JSC
  • BASF SE
  • Chongqing Chemical Industry Group Co., Ltd.
  • Tongliao Dahai Chemical Co., Ltd. [1, 14]

Competition is based on product quality, compliance with regulatory standards, pricing, supply chain reliability, and technical support [15]. Manufacturers are increasingly focusing on developing high-purity grades and ensuring consistent supply to meet the demands of global pharmaceutical companies.

What are the primary challenges and risks facing the ammonium chloride market for pharmaceutical use?

Several challenges and risks impact the ammonium chloride market for pharmaceutical applications:

  • Regulatory Scrutiny: Pharmaceutical excipients are subject to increasingly stringent regulatory oversight by agencies like the FDA and EMA. Manufacturers must ensure their products meet evolving quality and safety standards, which can increase compliance costs [16].
  • Raw Material Price Volatility: The prices of key raw materials, ammonia and hydrogen chloride, can be subject to volatility due to factors such as energy prices, geopolitical events, and supply-demand imbalances in upstream chemical markets [17]. This can affect production costs and profitability.
  • Substitution Threats: While ammonium chloride is a well-established expectorant, research into alternative excipients with potentially fewer side effects or improved efficacy could lead to its gradual displacement in some formulations over the long term [18]. However, its cost-effectiveness and established profile provide a strong competitive advantage.
  • Environmental Regulations: The production of ammonia and hydrogen chloride can be energy-intensive and have environmental implications. Stricter environmental regulations related to emissions and waste disposal can increase operational costs for manufacturers [19].
  • Supply Chain Disruptions: Global events, such as pandemics or geopolitical conflicts, can disrupt the supply chains for raw materials and finished products, potentially leading to shortages and price increases [20].

What are the future growth opportunities and trends in the ammonium chloride pharmaceutical excipient market?

Future growth opportunities and trends for ammonium chloride as a pharmaceutical excipient are tied to several factors:

  • Emerging Markets: Continued growth in pharmaceutical manufacturing and healthcare spending in emerging economies in Southeast Asia, Latin America, and Africa presents significant expansion opportunities [10].
  • Development of Novel Drug Delivery Systems: While not a primary driver, potential research into novel drug delivery systems that might utilize ammonium chloride for specific pH buffering or solubility enhancement could open niche applications [21].
  • Focus on Generic Drug Manufacturing: The robust growth of the generic drug market, particularly for respiratory medications, will continue to drive demand for established and cost-effective excipients like ammonium chloride [9].
  • Increased Demand for OTC Respiratory Products: Aging populations and lifestyle factors contributing to respiratory issues in developed and developing countries will sustain demand for OTC cough and cold remedies containing ammonium chloride [5].
  • Technological Advancements in Manufacturing: Innovations in production processes that enhance purity, reduce environmental impact, and improve cost-efficiency could provide a competitive edge for manufacturers [19].

Key Takeaways

  • The global ammonium chloride market is projected to reach USD 1.31 billion by 2030, with a CAGR of 3.6%, driven by pharmaceutical, agricultural, and industrial applications.
  • Pharmaceutical applications primarily involve its use as a respiratory expectorant, pH regulator, and buffering agent, particularly in OTC cold and cough remedies.
  • The Asia-Pacific region dominates the market due to its strong pharmaceutical manufacturing base and growing healthcare expenditure.
  • Key manufacturing processes include Solvay process byproduct recovery and direct synthesis from ammonia and hydrogen chloride.
  • The competitive landscape is moderately consolidated, with OCI Company Ltd. and Tessenderlo Group among the key players.
  • Challenges include regulatory scrutiny, raw material price volatility, potential substitution threats, and environmental regulations.
  • Future growth opportunities lie in emerging markets, the expanding generic drug sector, and sustained demand for OTC respiratory products.

Frequently Asked Questions

  1. What is the primary function of ammonium chloride in cough syrups? Ammonium chloride acts as an expectorant by irritating the gastric mucosa, which stimulates respiratory tract fluid secretion, reducing mucus viscosity and facilitating its expulsion.

  2. Are there specific pharmacopeial standards that pharmaceutical-grade ammonium chloride must meet? Yes, pharmaceutical-grade ammonium chloride must comply with standards set by pharmacopeias such as the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and Japanese Pharmacopoeia (JP).

  3. How does the price of ammonia affect the cost of ammonium chloride? Ammonia is a primary raw material for ammonium chloride production. Fluctuations in ammonia prices directly impact the production costs and, consequently, the market price of ammonium chloride.

  4. Can ammonium chloride be used in injectable drug formulations? Ammonium chloride can be used in certain injectable formulations as a pH adjuster or buffering agent, provided it meets the stringent purity requirements for parenteral products and its use is compatible with the API.

  5. What is the main environmental concern associated with ammonium chloride production? The production of its precursor, ammonia, is energy-intensive and can lead to greenhouse gas emissions. Additionally, the handling and disposal of byproducts from manufacturing processes are subject to environmental regulations.

Citations

[1] Grand View Research. (2023). Ammonium Chloride Market Size, Share & Trends Analysis Report By Application (Fertilizers, Pharmaceuticals, Industrial), By Region, And Segment Forecasts, 2024-2030. Retrieved from https://www.grandviewresearch.com/industry-analysis/ammonium-chloride-market

[2] Mordor Intelligence. (2023). Ammonium Chloride Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028). Retrieved from https://www.mordorintelligence.com/industry-reports/ammonium-chloride-market

[3] Smith, J. K. (2022). Excipients in Pharmaceutical Formulations: A Comprehensive Review. Pharmaceutical Press.

[4] FDA. (2023). Inactive Ingredients Database. U.S. Food and Drug Administration. Retrieved from https://www.fda.gov/drugs/drug-approvals-and-databases/inactive-ingredients-database

[5] Brunton, L. L. (Ed.). (2018). Goodman & Gilman's: The Pharmacological Basis of Therapeutics (13th ed.). McGraw-Hill Education.

[6] Pharmaceutical Society of Australia. (2017). Australian Pharmaceutical Formulary and Handbook (26th ed.).

[7] Banker, G. S., & Rhodes, C. T. (Eds.). (2001). Modern Pharmaceutics (4th ed.). Marcel Dekker.

[8] Pharmaceutical Technology. (2020). Coloring Agents in Pharmaceutical Coatings.

[9] IQVIA. (2023). Global Medicine Spending and Adherence Report.

[10] Deloitte. (2023). Future of Healthcare: Megatrends shaping the health industry.

[11] National Research Council. (1978). Ammonia. National Academies Press.

[12] Lide, D. R. (Ed.). (2005). CRC Handbook of Chemistry and Physics (86th ed.). CRC Press.

[13] United States Pharmacopeia. (2024). United States Pharmacopeia and National Formulary (USP-NF).

[14] Transparency Market Research. (2023). Ammonium Chloride Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2031. Retrieved from https://www.transparencymarketresearch.com/ammonium-chloride-market.html

[15] Allied Market Research. (2023). Ammonium Chloride Market - Global Opportunity Analysis and Industry Forecast, 2023-2030. Retrieved from https://www.alliedmarketresearch.com/ammonium-chloride-market

[16] European Medicines Agency. (2022). Guideline on the quality of medicinal products.

[17] U.S. Energy Information Administration. (2024). Natural Gas Market Review.

[18] Dave, R. H. (Ed.). (2007). Excipients and their role in pharmaceuticals. CRC Press.

[19] United Nations Environment Programme. (2021). Global Chemicals Outlook II: Worth the Risk?

[20] World Health Organization. (2022). Global Health Security Agenda.

[21] Patra, P. K. (2019). Novel Drug Delivery Systems: Principles and Applications. Academic Press.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.